[
    [
        {
            "time": "",
            "original_text": "马云收购爱康国宾真相何在？深挖阿里和腾讯医疗的投资差异",
            "features": {
                "keywords": [
                    "马云",
                    "收购",
                    "爱康国宾",
                    "阿里",
                    "腾讯",
                    "医疗",
                    "投资差异"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "健康"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "马云收购爱康国宾真相何在？深挖阿里和腾讯医疗的投资差异",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 7,
                "Time_Proximity": 5,
                "Headline_Structure": 9,
                "Source_Recency": 5
            }
        },
        {
            "time": "",
            "original_text": "爱康国宾私有化迷局：卖给阿里是最好的选择吗？",
            "features": {
                "keywords": [
                    "爱康国宾",
                    "私有化",
                    "阿里",
                    "选择"
                ],
                "sentiment_score": 0.4,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "健康"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "爱康国宾私有化迷局：卖给阿里是最好的选择吗？",
                "Correlation": 10,
                "Sentiment": 6,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 5,
                "Headline_Structure": 10,
                "Source_Recency": 5
            }
        },
        {
            "time": "",
            "original_text": "[增持评级]医药与健康护理行业信息点评：爱康国宾私有化出现阶段性进展 阿里巴巴或为最大赢家",
            "features": {
                "keywords": [
                    "增持评级",
                    "医药",
                    "健康护理",
                    "爱康国宾",
                    "私有化",
                    "阿里巴巴",
                    "赢家"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "健康"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[增持评级]医药与健康护理行业信息点评：爱康国宾私有化出现阶段性进展 阿里巴巴或为最大赢家",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-03-14",
            "original_text": "3月14日券商晨会研报汇编",
            "features": {
                "keywords": [
                    "券商晨会",
                    "研报汇编"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "3月14日券商晨会研报汇编",
                "Correlation": 3,
                "Sentiment": 5,
                "Importance": 4,
                "Impact": 3,
                "Duration": 3,
                "Entity_Density": 2,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 4,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "【晨会聚焦】持续看好成长和消费！ 医药行业深度：抗PD-1单抗",
            "features": {
                "keywords": [
                    "晨会聚焦",
                    "成长",
                    "消费",
                    "医药行业",
                    "抗PD-1单抗"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【晨会聚焦】持续看好成长和消费！ 医药行业深度：抗PD-1单抗",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-03-14",
            "original_text": "【医药】江琦、王超（联系人）：国务院机构改革为医药产业发展指明方向-20180314",
            "features": {
                "keywords": [
                    "医药",
                    "国务院",
                    "机构改革",
                    "产业发展",
                    "方向"
                ],
                "sentiment_score": 0.9,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【医药】江琦、王超（联系人）：国务院机构改革为医药产业发展指明方向-20180314",
                "Correlation": 4,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 2,
                "Market_Scope": 9,
                "Time_Proximity": 4,
                "Headline_Structure": 6,
                "Source_Recency": 3
            }
        }
    ]
]